Prognostic implication of myocardial perfusion and contractile reserve in end-stage renal disease: A direct comparison of myocardial perfusion scintigraphy and dobutamine stress echocardiography

[1]  Sean M. O'Brien,et al.  Management of Coronary Disease in Patients with Advanced Kidney Disease. , 2020, The New England journal of medicine.

[2]  L. Newby,et al.  Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[3]  J. Townend,et al.  Coronary microvascular dysfunction: a key step in the development of uraemic cardiomyopathy? , 2019, Heart.

[4]  M. Kharouta,et al.  Validation of a clinical pathway to assess asymptomatic renal transplant candidates using myocardial perfusion imaging , 2018, Journal of Nuclear Cardiology.

[5]  J. Sinisalo,et al.  Even mild reversible myocardial perfusion defects predict mortality in patients evaluated for kidney transplantation , 2018, European heart journal cardiovascular Imaging.

[6]  Keith C. Norris,et al.  Surveillance of CKD epidemiology in the US – a joint analysis of NHANES and KEEP , 2018, bioRxiv.

[7]  M. Oudkerk,et al.  Imaging the myocardial ischemic cascade , 2018, The International Journal of Cardiovascular Imaging.

[8]  M. Vervloet,et al.  Vascular calcification in chronic kidney disease: different bricks in the wall? , 2017, Kidney international.

[9]  R. Doukky,et al.  The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease , 2017, Journal of Nuclear Cardiology.

[10]  Andrew J Einstein,et al.  ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers , 2016, Journal of Nuclear Cardiology.

[11]  G. Prasad,et al.  Screening for cardiovascular disease before kidney transplantation. , 2015, World journal of transplantation.

[12]  B. Hesse,et al.  EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  J. Gottdiener,et al.  Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†. , 2015, European heart journal cardiovascular Imaging.

[14]  A. Webster,et al.  Prognostic Value of Cardiac Tests in Potential Kidney Transplant Recipients: A Systematic Review , 2015, Transplantation.

[15]  R. Doukky,et al.  Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation , 2015, Journal of Nuclear Cardiology.

[16]  J. Townend,et al.  Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance. , 2014, JACC. Cardiovascular imaging.

[17]  M. Moroi,et al.  Usefulness of stress myocardial perfusion imaging and baseline clinical factors for predicting cardiovascular events in patients with prior coronary artery disease. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[18]  Chi Pang Wen,et al.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention , 2013, The Lancet.

[19]  L. Shaw,et al.  ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[20]  B. Kasiske,et al.  Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation , 2012, Journal of the American College of Cardiology.

[21]  Jwa-Kyung Kim,et al.  Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis , 2011, Journal of Nuclear Cardiology.

[22]  Andrew Hayen,et al.  Cardiac testing for coronary artery disease in potential kidney transplant recipients. , 2011, The Cochrane database of systematic reviews.

[23]  H. Pavenstädt,et al.  Cardioprotective effect of calcineurin inhibition in an animal model of renal disease. , 2011, European heart journal.

[24]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[25]  R. Hendel,et al.  Comparison of dobutamine stress echocardiography, dobutamine SPECT, and adenosine SPECT myocardial perfusion imaging in patients with end-stage renal disease , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[26]  Jose Luis Zamorano,et al.  Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[27]  Patricia A Pellikka,et al.  American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  Neil R. Powe,et al.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. , 2007, Kidney international.

[29]  J. Griffith,et al.  The Framingham predictive instrument in chronic kidney disease. , 2007, Journal of the American College of Cardiology.

[30]  Kent R Bailey,et al.  Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. , 2007, American heart journal.

[31]  J. Foster,et al.  Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. , 2006, Kidney international.

[32]  B. Psaty,et al.  Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. , 2005, JAMA.

[33]  K. D. Workgroup.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[35]  H. Samady,et al.  Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. , 2004, American heart journal.

[36]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[37]  D. Cook,et al.  Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. , 2003, Journal of the American Society of Nephrology : JASN.

[38]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[39]  J. Kellum,et al.  Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). , 2013, Contributions to nephrology.

[40]  A. Hoes,et al.  [Guidelines on cardiovascular disease prevention in clinical practice]. , 2005, Revue medicale de Liege.